231
Participants
Start Date
September 30, 2021
Primary Completion Date
November 30, 2025
Study Completion Date
November 30, 2025
Efimosfermin
Efimosfermin will be administered by subcutaneous injection
Placebo
Placebo will be administered by subcutaneous injection
Coastal Research Institute, LLC, Fayetteville
Progressive Medical Research, Port Orange
Charter Research, Orlando
Panex Clinical Research, Miami Lakes
Evolution Clinical Trials, Hialeah Gardens
G+C Research Group, Miami
Miami Clinical Research, Miami
Advanced Clinical Research, Miami
Admed Research, Miami
Century Research, Miami
Entrust Clinical Research Center, Kendall
Southwest General Healthcare Center, Fort Myers
Covenant Metabolic Specialists - Fort Myers, Fort Myers
Galenus Group, Lehigh Acres
Covenant Metabolic Specialists - Sarasota, Sarasota
Central Research Associates, Birmingham
Lillestol Research LLC, Fargo
Kansas City Research Institute, Kansas City
Tandem Clinical Research, Marrero
South Texas Research Institute-Edinburg, Edinburg
Velocity Clinical Research - Waco, Waco
Houston Research Institute, Houston
Apex Mobile Clinical Research, Bellaire
LinQ Research, LLC, Pearland
Quality Research, Inc, San Antonio
American Research Corporation at Texas Liver Institute, San Antonio
Pinnacle Clinical Research - San Antonio, San Antonio
South Texas Research Institute-Brownsville, Brownsville
Pinnacle Clinical Research - Georgetown, Georgetown
Accelemed Research, Austin
Pinnacle Clinical Research - Austin, Austin
Texas Liver Institute - Austin, Austin
Olympus Family Medicine, Salt Lake City
South Ogden Family Medicine, South Ogden
Arizona Liver Health, Chandler
Arizona Liver Health, Peoria
Arizona Liver Health, Tucson
Liver Institute PPLC, Tucson
QLMC, Tucson
Alliance Research Institute, Canoga Park
Catalina Research Institute, Montclair
Inland Empire Clinical Trials, Rialto
Ark Clinical Research, Fountain Valley
Fresno Clinical Research Center, Fresno
Knowledge Research Center, Orange
FOMAT Medical Research, Oxnard
Liver Institute NorthWest, Seattle
Velocity Clinical Research, East Greenwich
Lead Sponsor
Collaborators (1)
GSK Research and Development Limited
UNKNOWN
Boston Pharmaceuticals
INDUSTRY